Uzonna JE - Search Results

1

Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells.

Uzonna JE, Joyce KL, Scott P. Uzonna JE, et al. J Exp Med. 2004 Jun 7;199(11):1559-66. doi: 10.1084/jem.20040172. J Exp Med. 2004. PMID: 15184505 Free PMC article.

2

Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites.

Zaph C, Uzonna J, Beverley SM, Scott P. Zaph C, et al. Nat Med. 2004 Oct;10(10):1104-10. doi: 10.1038/nm1108. Epub 2004 Sep 26. Nat Med. 2004. PMID: 15448686 Free article.

3

Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response.

Uzonna JE, Späth GF, Beverley SM, Scott P. Uzonna JE, et al. J Immunol. 2004 Mar 15;172(6):3793-7. doi: 10.4049/jimmunol.172.6.3793. J Immunol. 2004. PMID: 15004184

4

Immunization with persistent attenuated Delta lpg2 Leishmania major parasites requires adjuvant to provide protective immunity in C57BL/6 mice.

Kébaïer C, Uzonna JE, Beverley SM, Scott P. Kébaïer C, et al. Among authors: uzonna je. Infect Immun. 2006 Jan;74(1):777-80. doi: 10.1128/IAI.74.1.777-780.2006. Infect Immun. 2006. PMID: 16369039 Free PMC article.

5

The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development.

Scott P, Artis D, Uzonna J, Zaph C. Scott P, et al. Immunol Rev. 2004 Oct;201:318-38. doi: 10.1111/j.0105-2896.2004.00198.x. Immunol Rev. 2004. PMID: 15361250 Review.

6

Intradermal Synthetic DNA Vaccination Generates Leishmania-Specific T Cells in the Skin and Protection against Leishmania major.

Louis L, Clark M, Wise MC, Glennie N, Wong A, Broderick K, Uzonna J, Weiner DB, Scott P. Louis L, et al. Infect Immun. 2019 Jul 23;87(8):e00227-19. doi: 10.1128/IAI.00227-19. Print 2019 Aug. Infect Immun. 2019. PMID: 31182618 Free PMC article.

7

Control of New World cutaneous leishmaniasis is IL-12 independent but STAT4 dependent.

Buxbaum LU, Uzonna JE, Goldschmidt MH, Scott P. Buxbaum LU, et al. Among authors: uzonna je. Eur J Immunol. 2002 Nov;32(11):3206-15. doi: 10.1002/1521-4141(200211)32:11<3206::AID-IMMU3206>3.0.CO;2-J. Eur J Immunol. 2002. PMID: 12555666 Free article.

8

Efficacy of commercial and field-strain Mycobacterium paratuberculosis vaccinations with recombinant IL-12 in a bovine experimental infection model.

Uzonna JE, Chilton P, Whitlock RH, Habecker PL, Scott P, Sweeney RW. Uzonna JE, et al. Vaccine. 2003 Jul 4;21(23):3101-9. doi: 10.1016/s0264-410x(03)00261-5. Vaccine. 2003. PMID: 12804836

9

Leishmania major phosphoglycans influence the host early immune response by modulating dendritic cell functions.

Liu D, Kebaier C, Pakpour N, Capul AA, Beverley SM, Scott P, Uzonna JE. Liu D, et al. Among authors: uzonna je. Infect Immun. 2009 Aug;77(8):3272-83. doi: 10.1128/IAI.01447-08. Epub 2009 Jun 1. Infect Immun. 2009. PMID: 19487470 Free PMC article.

10

Tissue predilection sites and effect of dose on Mycobacterium avium subs. paratuberculosis organism recovery in a short-term bovine experimental oral infection model.

Sweeney RW, Uzonna J, Whitlock RH, Habecker PL, Chilton P, Scott P. Sweeney RW, et al. Res Vet Sci. 2006 Jun;80(3):253-9. doi: 10.1016/j.rvsc.2005.07.007. Epub 2005 Sep 13. Res Vet Sci. 2006. PMID: 16165171

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters